Hybio Pharmaceutical Co., Ltd

Unverified company

自从 2020

中国

我们的产品

查看所有产品

Ganirelix CAS123246-29-7

Name: Ganirelix Synonym: Antagon; orgalutran; Ganirelixum Cas No: 123246-29-7 Source: synthetic Ganirelix has potential

Curing Diabetics 204656-20-2 Peptide Liraglutide API

Function: Medical uses Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) gluca

Peptide Raw Powder Synthesis CAS 910463-68-2 Semaglutide API

Specification: Semaglutide is a glucagon-like peptide-1 (GLP-1) analog and functions as a GLP-1 agonist. It is indicated

Polypeptide API CAS 52232-67-4 to Treat Osteoporosis Teriparatide Acetate Raw Powder

Teriparatide Acetate (pTH (1-34) (human) acetate) is a polypeptide that consists of the 1-34 amino-acid fragment of huma

关于我们

Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, but some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company. Our GMP plant in Shenzhen is a facility occupying an area of more than 1,5000 sq.m. It has been often audited and inspected by local/national s-FDA authorities and by clients all over the world.

主要市场

非洲亚洲北美大洋洲南美洲西南亚西欧

非洲
亚洲
北美
大洋洲
南美洲
西南亚
西欧

更多关于
Hybio Pharmaceutical Co., Ltd

500-1000

员工

1

销售额（美元）

40%

% 出口销售额

1998

Year

成立年份

业务类型

Industry / Manufacturer
Business Service

关键词

多肽原料药
制剂
利拉鲁肽
索马鲁肽
阿托西班
特利加压素
加尼瑞克
格拉替雷
依替巴肽
去氨加压素

Ver Mais

联系方式和位置

Andrew Li
+86 xxxxxxxx
深圳 / | 中国

提出您的要求